AWM Investment Company’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-613,795
Closed -$2.71M 101
2018
Q1
$2.71M Sell
613,795
-863,622
-58% -$3.85M 0.52% 54
2017
Q4
$7.77M Sell
1,477,417
-85,100
-5% -$521K 1.51% 21
2017
Q3
$9.58M Sell
1,562,517
-25,103
-2% -$159K 1.67% 20
2017
Q2
$11.5M Buy
1,587,620
+525,000
+49% +$3.23M 2.03% 18
2017
Q1
$5.63M Buy
1,062,620
+57,620
+6% +$389K 1.05% 30
2016
Q4
$7.22M Hold
1,005,000
1.41% 21
2016
Q3
$9.41M Sell
1,005,000
-111,255
-10% -$924K 1.72% 17
2016
Q2
$7.05M Sell
1,116,255
-103,580
-8% -$666K 1.51% 23
2016
Q1
$6.73M Buy
1,219,835
+752,328
+161% +$2.83M 1.41% 27
2015
Q4
$2.61M Sell
467,507
-282,493
-38% -$1.87M 0.51% 48
2015
Q3
$6.34M Buy
750,000
+150,000
+25% +$2.54M 1.23% 27
2015
Q2
$9.07M Hold
600,000
1.29% 24
2015
Q1
$9.61M Hold
600,000
1.33% 22
2014
Q4
$10.7M Buy
+600,000
New +$7.48M 1.46% 19

Other funds holding PETX

AWM Investment Company's PETX Position: Q2 2018 in Review

AWM Investment Company sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2018, closing a stake of 613,795 shares — an estimated $2.71M sold.

AWM Investment Company first reported a position in PETX in Q4 2014 and held it in 14 quarters. The position peaked at $11.5M in Q2 2017. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2018.

  • AWM Investment Company reported no remaining Aratana Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • AWM Investment Company sold 613,795 Aratana Therapeutics, Inc. shares in Q2 2018, an estimated $2.71M.
  • AWM Investment Company first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and held it in 14 quarters.
  • AWM Investment Company's Aratana Therapeutics, Inc. position peaked at $11.5M in Q2 2017.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2018.

Based on AWM Investment Company's 13F filing for Q2 2018, filed 9 Aug 2018.